Kai‐Li Liaw - Concepedia

Author

Kai‐Li Liaw

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

K. Liaw, K.-L. Liaw, K.‐L. Liaw, Kai-Li Liaw, Kai‐Li Liaw, Kai–Li Liaw, Liaw, Kai-Li

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Danish Cancer Society Rigshospitalet Karolinska Institutet National Cancer Institute

About

Kai‐Li Liaw is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in public health, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	10	10	505
2	Medicine	9	9	598
3	Engineering	1	1	15
4	Health Sciences	1	1	135
5	Social Sciences	1	1	27

Kai‐Li Liaw

Publications

Citations

H-Index

Page 1

	Year	Citations
A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types Kai‐Li Liaw, Allan Hildesheim, Robert D. Burk, The Journal of Infectious Diseases Viral DiagnosticsPathologyGynecologyNucleic Acid Amplification TestReal-time Polymerase Chain Reaction	2001	297
The Burden of Genital Warts: A Study of Nearly 70,000 Women from the General Female Population in the 4 Nordic Countries Susanne K. Kjær, Trung N. Tran, Pär Sparén, The Journal of Infectious Diseases	2007	237
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine Chun Chao, Nicola P. Klein, Christine Velicer, Journal of Internal Medicine	2011	197
Epidemiology of Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (dMMR) in Solid Tumors: A Structured Literature Review Maria Lorenzi, Mayur M. Amonkar, Jacky Zhang, Journal of Oncology Structured Literature ReviewGeneticsDmmr PrevalencePathologyTumor Biology	2020	135
Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females Nicola P. Klein, John Hansen, Chun Chao, Archives of Pediatrics and Adolescent Medicine	2012	115
Incidence and Duration of Cervical Human Papillomavirus 6, 11, 16, and 18 Infections in Young Women: An Evaluation from Multiple Analytic Perspectives Ralph P. Insinga, Erik J. Dasbach, Elamin H. Elbasha, Cancer Epidemiology Biomarkers & Prevention	2007	109
Human papillomavirus and cervical neoplasia: A case‐control study in Taiwan Kai‐Li Liaw, Ann W. Hsing, Chem‐Jen Chen, International Journal of Cancer	1995	102
Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women Ralph P. Insinga, Erik J. Dasbach, Elamin H. Elbasha, Infectious Agents and Cancer	2007	77
Estimating the Incidence and Prevalence of Juvenile-Onset Recurrent Respiratory Papillomatosis in Publicly and Privately Insured Claims Databases in the United States Mark Marsico, Vinay Mehta, Benjamin Chastek, Sexually Transmitted Diseases	2014	62
Age at first intercourse, number of partners and sexually transmitted infection prevalence among Danish, Norwegian and Swedish women: estimates and trends from nationally representative cross‐sectional surveys of more than 100 000 women Bo T. Hansen, Susanne K. Kjær, Lisen Arnheim‐Dahlström, Acta Obstetricia Et Gynecologica Scandinavica	2019	59

Page 1